VIRAL UPPER RESPIRATORY TRACT INFECTION side effect
What is VIRAL UPPER RESPIRATORY TRACT INFECTION ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
VIRAL UPPER RESPIRATORY TRACT INFECTION and Recently Reported Side Effects
VIRAL UPPER RESPIRATORY TRACT INFECTION and 15 most Active Side Effect polls
VIRAL UPPER RESPIRATORY TRACT INFECTION and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Drugs associated with VIRAL UPPER RESPIRATORY TRACT INFECTION
ETOPOSIDE FLOVENT LUNESTA PULMICORT RENAGEL REVLIMID SOMATROPIN THIOGUANINERevlimid Side Effects Report #5656175-X
Physician from GERMANY reported REVLIMID problem on Feb 25, 2008. Female patient, 64 years of age, weighting 196.2 lb, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: vasculitis, viral upper respiratory tract infection, . REVLIMID dosage: 25 MG, DAILY, ORAL. Patient was hospitalized. Patient recovered.
Renagel Side Effects Report #5663819-5
RENAGEL problem was reported by a Health Professional from GREECE on Feb 26, 2008. Female patient, 50 years of age, was diagnosed with hyperphosphataemia and was treated with RENAGEL. After drug was administered, patient experienced the following problems/side effects: myalgia, viral upper respiratory tract infection, . RENAGEL dosage: unknown. During the same period patient was treated with PEPSAMAR, INSULIN, ACE INHIBITOR NOS. Patient was hospitalized. Patient recovered.
Renagel Side Effects Report #5635830-1
Physician from GREECE reported RENAGEL problem on Feb 07, 2008. Female patient, 50 years of age, was diagnosed with hyperphosphataemia and was treated with RENAGEL. After drug was administered, patient experienced the following problems/side effects: myalgia, viral upper respiratory tract infection, . RENAGEL dosage: unknown. During the same period patient was treated with PEPSAMAR, INSULIN, ALPHA MEA. Patient was hospitalized. Patient recovered.
Revlimid Side Effects Report #5640249-3
REVLIMID problem was reported by a Physician from GERMANY on Feb 15, 2008. Female patient, 64 years of age, weighting 196.2 lb, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: vasculitis, viral upper respiratory tract infection, . REVLIMID dosage: 25 MG, DAILY, ORAL. Patient was hospitalized. Patient recovered.
Lunesta Side Effects Report #5410090-5
Consumer or non-health professional from UNITED STATES reported LUNESTA problem on June 06, 2007. Male patient, 27 years of age, was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: dysgeusia, viral upper respiratory tract infection, . LUNESTA dosage: 2 MG;HS;ORAL. Patient recovered.
Lunesta Side Effects Report #5410090-5
LUNESTA problem was reported by a Consumer or non-health professional from UNITED STATES on June 06, 2007. Male patient, 27 years of age, was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: dysgeusia, viral upper respiratory tract infection, . LUNESTA dosage: 2 MG;HS;ORAL. Patient recovered.
Flovent Side Effects Report #5471182-8
Consumer or non-health professional from UNITED STATES reported FLOVENT problem on July 23, 2007. Female patient, 64 years of age, was diagnosed with asthma and was treated with FLOVENT. After drug was administered, patient experienced the following problems/side effects: dysphonia, viral upper respiratory tract infection, . FLOVENT dosage: unknown. During the same period patient was treated with AVALIDE, COMBIVENT. Patient recovered.
Pulmicort Side Effects Report #5785910-5
PULMICORT FLEXHALER problem was reported by a Consumer or non-health professional from UNITED STATES on May 24, 2007. Male patient, 82 years of age, weighting 216.1 lb, was diagnosed with cough, gastrooesophageal reflux disease and was treated with PULMICORT FLEXHALER. After drug was administered, patient experienced the following problems/side effects: cough, lung disorder, viral upper respiratory tract infection, . PULMICORT FLEXHALER dosage: unknown. During the same period patient was treated with PULMICORT FLEXHALER, BICALUTAMIDE, DIGOXIN, SIMVASTATIN, QUINAPRIL, NEXIUM, ZEGERID, VIADUR. Patient recovered.
Somatropin Side Effects Report #5798824-1
Physician from UNITED KINGDOM reported SOMATROPIN problem on May 22, 2006. Male patient, 14 years of age, was diagnosed with prader-willi syndrome and was treated with SOMATROPIN. After drug was administered, patient experienced the following problems/side effects: respiratory failure, right ventricular failure, viral upper respiratory tract infection, . SOMATROPIN dosage: 0.11 MG. Patient died.
Etoposide Side Effects Report #5707820-1
ETOPOSIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 14, 2008. Female patient was diagnosed with acute myeloid leukaemia and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: cardiac failure congestive, shock, viral upper respiratory tract infection, . ETOPOSIDE dosage: 100 MG/M2. During the same period patient was treated with DAUNORUBICIN, MITOXANTRONE, CYTARABINE, THIOGUANINE. Patient died.
Thioguanine Side Effects Report #5725216-3
Consumer or non-health professional from UNITED STATES reported THIOGUANINE problem on Apr 17, 2008. Female patient was diagnosed with acute myeloid leukaemia and was treated with THIOGUANINE. After drug was administered, patient experienced the following problems/side effects: cardiac failure congestive, shock, viral upper respiratory tract infection, . THIOGUANINE dosage: 100 MG/M2/PER DAY/ORAL. During the same period patient was treated with CYTARABINE, DAUNORUBICIN, ETOPOSIDE, MITOXANTRONE. Patient died.
Flovent Side Effects Report #5375007-0
FLOVENT problem was reported by a Consumer or non-health professional from UNITED STATES on June 18, 2007. Female patient, 64 years of age, was diagnosed with asthma and was treated with FLOVENT. After drug was administered, patient experienced the following problems/side effects: dysphonia, viral upper respiratory tract infection, . FLOVENT dosage: unknown. During the same period patient was treated with AVALIDE, COMBIVENT. Patient recovered.